BioSpace News Archive

Natus Medical Incorporated announced its first quarter revenue estimate and withdrew its full year 2020 guidance.

Company to Host Audio Webcast and Conference Call of First Quarter 2020 Results on May 11, 2020

Atreca, Inc., a biotechnology company focused on developing novel therapeutics generated through a unique discovery platform based on interrogation of the active human immune response, announced that it will participate in two upcoming investor conferences

Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors, reported interim results from the ongoing ACROBAT Edge Phase 2 trial.

AACC is pleased to announce that the organization will be able to preserve the complete 2020 AACC Annual Scientific Meeting & Clinical Lab Expo experience for its attendees by moving the meeting to December 13-17, 2020.

Encompass Health Corp. announced it will award frontline employees in its 134 hospitals, 245 home health locations and 83 hospice locations with additional paid time off in recognition of their outstanding efforts during the COVID-19 outbreak.

BD announced that it will conduct a live webcast of its second fiscal quarter 2020 earnings conference call on Thursday, May 7, 2020, at 8:00 a.m.

IQVIA™, a leader in Human Data Science, announced its new technology-enabled COVID-19 Trial Matching Tool at c19trials.com, which is one of the world’s first online platforms that matches individuals with specific COVID-19 studies to accelerate clinical research projects.

Imports to supplement the 35 million N95 respirators 3M currently produces in U.S. per month

Seoul National University Hospital, Seoul, South Korea, treats COVID-19 patients with mild or no symptoms at an isolation facility called “Life Treatment Center.” This measure came after the confirmed COVID-19 cases started to soar at the end of February in order to secure medical care for those with catastrophic illnesses and rare and intractable diseases.